Document is current
Any future updates will be listed below
-
Authors
Osbelt, Lisa https://orcid.org/0000-0002-4862-650X
Almási, Éva d. H. https://orcid.org/0000-0001-5042-5478
Wende, Marie
Kienesberger, Sabine https://orcid.org/0000-0003-3190-3678
Voltz, Alexander
Lesker, Till R.
Muthukumarasamy, Uthayakumar
Knischewski, Nele
Nordmann, Elke
Bielecka, Agata A.
Giralt-Zúñiga, María https://orcid.org/0009-0000-6376-7258
Kaganovitch, Eugen
Kühne, Caroline
Baier, Claas
Pietsch, Michael
Müsken, Mathias https://orcid.org/0000-0002-5624-1378
Greweling-Pils, Marina C.
Breinbauer, Rolf https://orcid.org/0000-0001-6009-7359
Flieger, Antje
Schlüter, Dirk
Müller, Rolf https://orcid.org/0000-0002-1042-5665
Erhardt, Marc https://orcid.org/0000-0001-6292-619X
Zechner, Ellen L. https://orcid.org/0000-0003-2035-1898
Strowig, Till https://orcid.org/0000-0003-0185-1459
-
Funding
Funding for this research was provided by:
Joint Programming Initiative on Antimicrobial Resistance (01KI1824)
- License Information
-
More Information
Article History
Received: 6 June 2023
Accepted: 22 April 2024
First Online: 11 June 2024
Inclusion and ethics
: We support inclusive, diverse, and equitable conduct of research.
: L.O., M.W. and T.S. have filed a patent for the use of <i>K. oxytoca</i> to decolonize MDR Enterobacteriaceae from the gut (EP4259171A1, EP4011384A1, WO002022122825A1 and US020240041950A1). The other authors declare no competing interests.
